{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:17:15Z","timestamp":1794215835985,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fudan University Affiliated Jinshan Hospital youth Research Fund","award":["JYQN- JC-202305"],"award-info":[{"award-number":["JYQN- JC-202305"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metab"],"DOI":"10.1186\/s40170-025-00373-7","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:19:45Z","timestamp":1737969585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGF\u03b2 signaling pathway"],"prefix":"10.1186","volume":"13","author":[{"given":"Wenjing","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"373_CR1","first-page":"325","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism, Nature reviews. Cancer. 2011;11:325\u201337.","journal-title":"Cancer"},{"key":"373_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"373_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13402-023-00852-3","volume":"47","author":"PC Chen","year":"2024","unstructured":"Chen PC, Ning Y, Li H, Su JG, Shen JB, Feng QC, Jiang SH, Shi PD, Guo RS. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Cell Oncol. 2024;47:81\u201396.","journal-title":"Cell Oncol"},{"key":"373_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discovery. 2022;21:141\u201362.","journal-title":"Nat Rev Drug Discovery"},{"key":"373_CR5","doi-asserted-by":"crossref","unstructured":"Barba I, Carrillo-Bosch L, Seoane J. Targeting the Warburg Effect in Cancer: where do we stand? Int J Mol Sci, 25 (2024).","DOI":"10.3390\/ijms25063142"},{"key":"373_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41571-021-00593-y","volume":"19","author":"AK Dutta","year":"2022","unstructured":"Dutta AK, Alberge JB, Sklavenitis-Pistofidis R, Lightbody ED, Getz G, Ghobrial IM. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine. Nat Reviews Clin Oncol. 2022;19:223\u201336.","journal-title":"Nat Reviews Clin Oncol"},{"key":"373_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN. Diagnosis and management of multiple myeloma a review. Jama-J Am Med Assoc. 2022;327:464\u201377.","journal-title":"Jama-J Am Med Assoc"},{"key":"373_CR8","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s13402-023-00817-6","volume":"46","author":"L Li","year":"2023","unstructured":"Li L, Hu XY, Nkwocha J, Sharma K, Kmieciak M, Mann H, Zhou L, Grant S. Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells. Cell Oncol. 2023;46:1369\u201380.","journal-title":"Cell Oncol"},{"key":"373_CR9","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, H\u00e1jek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U. E.G.C. ESMO, Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upvol 33, pg 117, (2022), Annals of Oncology, 33 (2022) 988\u2013988.","DOI":"10.1016\/j.annonc.2022.05.004"},{"key":"373_CR10","doi-asserted-by":"crossref","unstructured":"Wallington-Beddoe CT, Mynott RL. Prognostic and predictive biomarker developments in multiple myeloma. J Hematol Oncol, 14 (2021).","DOI":"10.1186\/s13045-021-01162-7"},{"key":"373_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1200\/JOP.19.00335","volume":"16","author":"RD Parrondo","year":"2020","unstructured":"Parrondo RD, Ailawadhi S, Sher T, Chanan-Khan AA, Roy V. Autologous stem-cell transplantation for multiple myeloma in the era of Novel therapies. Jco Oncol Pract. 2020;16:56\u201366.","journal-title":"Jco Oncol Pract"},{"key":"373_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14656566.2021.1999411","volume":"23","author":"M Gavriatopoulou","year":"2022","unstructured":"Gavriatopoulou M, Malandrakis P, Ntanasis-Stathopoulos I, Dimopoulos MA. Nonselective proteasome inhibitors in multiple myeloma and future perspectives. Expert Opin Pharmaco. 2022;23:335\u201347.","journal-title":"Expert Opin Pharmaco"},{"key":"373_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1172\/JCI129205","volume":"130","author":"SA Minnie","year":"2020","unstructured":"Minnie SA, Hill GR. Immunotherapy of multiple myeloma. J Clin Invest. 2020;130:1565\u201375.","journal-title":"J Clin Invest"},{"key":"373_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"DD Wang","year":"2021","unstructured":"Wang DD, Day EA, Townsend LK, Djordjevic D, Jorgensen SB, Steinberg GR. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol. 2021;17:592\u2013607.","journal-title":"Nat Rev Endocrinol"},{"key":"373_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","volume":"64","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui JA, Pothuraju R, Khan P, Sharma G, Muniyan S, Seshacharyulu P, Jain M, Nasser MW, Batra SK. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. Cytokine Growth F R. 2022;64:71\u201383.","journal-title":"Cytokine Growth F R"},{"key":"373_CR16","doi-asserted-by":"crossref","unstructured":"Rybicki BA, Chitale D, Gupta N, Jackson L, Wheeler T, Trudeau S, Jankowski M, Bobbittt K, Rundle A, Tang DL. The changing role of GDF15 (growth\/differentiation factor 15) during prostate carcinogenesis. Cancer Res, 75 (2015).","DOI":"10.1158\/1538-7445.AM2015-849"},{"key":"373_CR17","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/carcin\/bgaa065","volume":"41","author":"SM Sadasivan","year":"2020","unstructured":"Sadasivan SM, Chen YL, Gupta NS, Han XX, Bobbitt KR, Chitale DA, Williamson SR, Rundle AG, Tang DL, Rybicki BA. The interplay of growth differentiation factor 15 (GDF15) expression and M2 macrophages during prostate carcinogenesis. Carcinogenesis. 2020;41:1074\u201382.","journal-title":"Carcinogenesis"},{"key":"373_CR18","doi-asserted-by":"crossref","unstructured":"Tanno T, Merchant A, Agarwal JR, Wang QJ, Matsui W. The TGF- \u03b2 Family Member Growth Differentiation Factor 15 (GDF15) Regulates the Self-Renewal of Multiple Myeloma Cancer Stem Cells, Blood, 118 (2011) 1275\u20131275.","DOI":"10.1182\/blood.V118.21.2954.2954"},{"key":"373_CR19","doi-asserted-by":"crossref","unstructured":"Wu Q, Ren W, Ye S, Koenigshoff M, Eickelberg O. Growth differentiation factor 15 (GDF15)-Mediated lung aging promotes human rhinovirus infection and Virus-Induced inflammation. Am J Resp Crit Care, 199 (2019).","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A5756"},{"key":"373_CR20","doi-asserted-by":"crossref","unstructured":"Kim-Muller JY, Song LJ, Paulhus BL, Pashos E, Li XP, Rinaldi A, Joaquim S, Stansfield JC, Zhang JW, Robertson A, Pang JC, Opsahl A, Boucher M, Breen D, Hales K, Sheikh A, Wu ZD, Zhang BB. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia. Cell Rep, 42 (2023).","DOI":"10.1016\/j.celrep.2022.111947"},{"key":"373_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000519888","volume":"145","author":"J Hidman","year":"2022","unstructured":"Hidman J, Larsson A, Thulin M, Karlsson T. Increased plasma GDF15 is Associated with altered levels of Soluble VEGF receptors 1 and 2 in symptomatic multiple myeloma. Acta Haematol-Basel. 2022;145:326\u201333.","journal-title":"Acta Haematol-Basel"},{"key":"373_CR22","doi-asserted-by":"crossref","unstructured":"Banaszkiewicz M, Malyszko J, Batko K, Koc-Zorawska E, Zorawski M, Dumnicka P, Jurczyszyn A, Woziwodzka K, Tisonczyk J, Krzanowski M, Malyszko J, Waszczuk-Gajda A, Drozdz R, Kuzniewski M, Krzanowska K. Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma, Mediators of inflammation, 2020 (2020).","DOI":"10.1155\/2020\/5657864"},{"key":"373_CR23","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1158\/0008-5472.CAN-06-4046","volume":"67","author":"WJ Chng","year":"2007","unstructured":"Chng WJ, Kumar S, VanWier S, Ahmann G, Price-Troska T, Henderson K, Chung TH, Kim S, Mulligan G, Bryant B, Carpten J, Gertz M, Rajkumar SV, Lacy M, Dispenzieri A, Kyle R, Greipp P, Bergsagel PL, Fonseca R. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res. 2007;67:2982\u20139.","journal-title":"Cancer Res"},{"key":"373_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1182\/blood-2016-01-696617","volume":"128","author":"A Artz","year":"2016","unstructured":"Artz A, Butz S, Vestweber D. GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5\/TGF-\u03b2RII heterodimer. Blood. 2016;128:529\u201341.","journal-title":"Blood"},{"key":"373_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000202804.84885.d0","volume":"98","author":"J Xu","year":"2006","unstructured":"Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. GDF15\/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circul Res. 2006;98:342\u201350.","journal-title":"Circul Res"},{"key":"373_CR26","doi-asserted-by":"crossref","unstructured":"Gauthier T, Yao C, Dowdy T, Jin WW, Lim YJ, Patino LC, Liu N, Ohlemacher SI, Bynum A, Kazmi R, Bewley CA, Mitrovic M, Martin D, Morell RJ, Eckhaus M, Larion M, Tussiwand R, O\u2019Shea JJ, Chen WJ. TGF-\u03b2 uncouples glycolysis and inflammation in macrophages and controls survival during sepsis. Sci Signal, 16 (2023).","DOI":"10.1126\/scisignal.ade0385"},{"key":"373_CR27","doi-asserted-by":"crossref","unstructured":"Huang YW, Chen ZC, Lu T, Bi GS, Li M, Liang JQ, Hu ZY, Zheng YS, Yin JC, Xi JJ, Lin ZW, Zhan C, Jiang W, Wang Q, Tan LJ. HIF-1\u03b1 switches the functionality of TGF-\u03b2 signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer. J Exp Clin Canc Res, 40 (2021).","DOI":"10.1186\/s13046-021-02188-y"},{"key":"373_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cmet.2023.01.001","volume":"35","author":"YY Zhang","year":"2023","unstructured":"Zhang YY, Zhao XY, Dong XN, Zhang YY, Zou HX, Jin YG, Guo W, Zhai P, Chen X, Kharitonenkov A. Activity-balanced GLP-1\/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates. Cell Metabol. 2023;35:287\u2013.","journal-title":"Cell Metabol"},{"key":"373_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmet.2022.12.011","volume":"35","author":"O Benichou","year":"2023","unstructured":"Benichou O, Coskun T, Gonciarz MD, Garhyan P, Adams AC, Du Y, Dunbar JD, Martin JA, Mather KJ, Pickard RT, Reynolds VL, Robins DA, Zvada SP, Emmerson PJ. Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist. Cell Metabol. 2023;35:274\u2013.","journal-title":"Cell Metabol"},{"key":"373_CR30","unstructured":"Sokol R.J., Friederich M.W., Strode D.K., Van Hove R.A., Miller K., Gabel L., Horslen S.P., Kohli R., Lovell M.A., Miethke A., Molleston J.P., Romero R., Squires J.E., Squires R.H., Sundaram S.S., Magee J.C., Van Hove J.L.K., Network C.L.D.R. Accuracy of Gdf15 and Fgf21 to differentiate mitochondrial hepatopathies from other Pediatric Liver diseases. Hepatology. 2022;76:S200\u20131."},{"key":"373_CR31","doi-asserted-by":"crossref","unstructured":"Klein AB, Nicolaisen TS, Johann K, Fritzen AM, Mathiesen CV, Gil C, Pilmark NS, Karstoft K, Blond MB, Quist JS, Seeley RJ, F\u00e6rch K, Lund J, Kleinert M, Clemmensen C. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance. Cell Rep, 40 (2022).","DOI":"10.1101\/2022.02.16.480373"},{"key":"373_CR32","doi-asserted-by":"crossref","unstructured":"He RZ, Shi JJ, Xu DP, Yang J, Shen Y, Jiang YS, Tao LY, Yang MW, Fu XL, Yang JY, Liu DJ, Huo YM, Shen XQ, Lu P, Niu NN, Sun YW, Xue J. SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer. Cancer Lett, 538 (2022).","DOI":"10.1016\/j.canlet.2022.215693"},{"key":"373_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cmet.2022.03.005","volume":"34","author":"S Katsumura","year":"2022","unstructured":"Katsumura S, Siddiqui N, Goldsmith MR, Cheah JH, Fujikawa T, Minegishi G, Yamagata A, Yabuki Y, Kobayashi K, Shirouzu M, Inagaki T, Huang THM, Musi N, Topisirovic I, Larsson O, Morita M. Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure. Cell Metabol. 2022;34:564\u2013.","journal-title":"Cell Metabol"},{"key":"373_CR34","doi-asserted-by":"crossref","unstructured":"Lin HP, Luo Y, Gong TY, Fang HS, Li H, Ye GY, Zhang Y, Zhong M. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer. Cell Oncol, (2024).","DOI":"10.1007\/s13402-024-00918-w"},{"key":"373_CR35","doi-asserted-by":"crossref","unstructured":"Wang ZY, Wang SJ, Jia ZH, Hu YP, Cao DY, Yang MJ, Liu LG, Gao L, Qiu SM, Yan WK, Li YM, Luo J, Geng YJ, Zhang JY, Li ZZ, Wang X, Li ML, Shao R, Liu YB. YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer. Cancer Lett, 563 (2023).","DOI":"10.1016\/j.canlet.2023.216184"},{"key":"373_CR36","doi-asserted-by":"crossref","unstructured":"Joo M, Kim D, Lee MW, Lee HJ, Kim JM. GDF15 promotes cell growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 activation. Int J Mol Sci, 24 (2023).","DOI":"10.3390\/ijms24032925"},{"key":"373_CR37","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"LD Yang","year":"2017","unstructured":"Yang LD, Chang CC, Sun Z, Madsen D, Zhu HS, Padkj\u00e6r SB, Wu XA, Huang T, Hultman K, Paulsen SJ, Wang JS, Bugge A, Frantzen JB, Norgaard P, Jeppesen JF, Yang ZR, Secher A, Chen HB, Li X, John LM, Shan B, He ZH, Gao X, Su J, Hansen KT, Yang W, Jorgensen SB. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23:1158\u2013.","journal-title":"Nat Med"},{"key":"373_CR38","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, Coskun T, Hamang MJ, Sindelar DK, Ballman KK, Foltz LA, Muppidi A, Alsina-Fernandez J, Barnard GC, Tang JX, Liu XL, Mao XD, Siegel R, Sloan JH, Mitchell PJ, Zhang BB, Gimeno RE, Shan B, Wu XL. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017;23:1215\u2013.","journal-title":"Nat Med"},{"key":"373_CR39","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican SE, Lin-Schmidt X, Chin CN, Chavez JA, Furman JL, Armstrong AA, Beck SC, South VJ, Dinh TQ, Cash-Mason TD, Cavanaugh CR, Nelson S, Huang CC, Hunter MJ, Rangwala SM. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med. 2017;23:1150\u2013.","journal-title":"Nat Med"},{"key":"373_CR40","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","volume":"26","author":"R Suriben","year":"2020","unstructured":"Suriben R, Chen M, Higbee J, Oeffinger J, Ventura R, Li B, Mondal K, Gao ZY, Ayupova D, Taskar P, Li DN, Starck SR, Chen HIH, McEntee M, Katewa SD, Phung V, Wang M, Kekatpure A, Lakshminarasimhan D, White A, Olland A, Haldankar R, Solloway MJ, Hsu JY, Wang Y, Tang J, Lindhout DA, Allan BB. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat Med. 2020;26:1264\u2013.","journal-title":"Nat Med"},{"key":"373_CR41","doi-asserted-by":"crossref","unstructured":"Xie BK, Tang WJ, Wen SA, Chen F, Yang C, Wang M, Yang Y, Liang W. GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL\/RET Signaling Complex, Biomolecules, 14 (2024).","DOI":"10.3390\/biom14010038"},{"key":"373_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000354835","volume":"131","author":"P Tarkun","year":"2014","unstructured":"Tarkun P, Atesoglu EB, Mehtap O, Musul MM, Hacihanefioglu A. Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients. Acta Haematol-Basel. 2014;131:173\u20138.","journal-title":"Acta Haematol-Basel"},{"key":"373_CR43","doi-asserted-by":"crossref","unstructured":"Wang ZW, He L, Li WN, Xu CY, Zhang JY, Wang DS, Dou KF, Zhuang R, Jin BQ, Zhang W, Hao Q, Zhang K, Zhang WQ, Wang SN, Gao Y, Gu JT, Shang L, Tan ZJ, Su HC, Zhang YQ, Zhang C, Li M. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer, 9 (2021).","DOI":"10.1136\/jitc-2021-002787"},{"key":"373_CR44","doi-asserted-by":"crossref","unstructured":"Breen DM, Jagarlapudi S, Patel A, Zou C, Joaquim S, Li XP, Kang LY, Pang JC, Hales K, Ziso-Qejvanaj E, Vera NB, Bennett D, He T, Lambert M, Kelleher K, Wu ZD, Zhang BB, Lin L, Seeley RJ. O. Bezy, Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation. Iscience; 2021. p. 24.","DOI":"10.1016\/j.isci.2021.102554"},{"key":"373_CR45","doi-asserted-by":"crossref","unstructured":"Carneiro BA, Gbolahan O, Razak AA, Hilton JF, Lambert A, Hood J, Pluta M, Bragulat V, Sanai E, Kumar R, Jodrell D, LoRusso P. Safety and efficacy of AZD8853, an anti-growth and differentiation factor 15 (GDF15) antibody, in patients (pts) with advanced\/metastatic solid tumors: first-in-human study. Cancer Res, 84 (2024).","DOI":"10.1158\/1538-7445.AM2024-CT100"}],"container-title":["Cancer &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-025-00373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40170-025-00373-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-025-00373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:20:04Z","timestamp":1737969604000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerandmetabolism.biomedcentral.com\/articles\/10.1186\/s40170-025-00373-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1186\/s40170-025-00373-7","relation":{},"ISSN":["2049-3002"],"issn-type":[{"value":"2049-3002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}